RASCHI, EMANUEL
RASCHI, EMANUEL
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study
2025 Donati, M.; Giunchi, V.; Grillini, G.; Domenicali, M.; Lunardelli, M. L.; Pasini, V.; Milandri, S.; Mussoni, M.; Pieraccini, F.; Sangiorgi, E.; Raschi, E.; Colonnello, V.; Lunghi, C.; Poluzzi, E.
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
2025 Armillotta, Matteo; Angeli, Francesco; Paolisso, Pasquale; Belmonte, Marta; Raschi, Emanuel; Di Dalmazi, Guido; Amicone, Sara; Canton, Lisa; Fedele, Damiano; Suma, Nicole; Foà, Alberto; Bergamaschi, Luca; Pizzi, Carmine
Comment on “evaluation of anticancer therapy-related dermatologic adverse events: insight from Food and Drug Administration’s adverse event reporting system dataset”.
2025 Raschi, E; La Placa, M; Starace, M.
Safety of Hydroxychloroquine: What a Dermatologist Should Know
2025 Rapparini, Luca; Cedirian, Stephano; La Placa, Michelangelo; Piraccini, Bianca Maria; Raschi, Emanuel; Starace, Michela
The interface of depression and diabetes: treatment considerations
2025 Fanelli, G.; Raschi, E.; Hafez, G.; Matura, S.; Schiweck, C.; Poluzzi, E.; Lunghi, C.
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals
2024 Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E.
Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database
2024 De Filippis, R.; Kane, J. M.; Arzenton, E.; Moretti, U.; Raschi, E.; Trifiro, G.; Barbui, C.; De Fazio, P.; Gastaldon, C.; Schoretsanitis, G.
Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality
2024 Schoretsanitis, G.; Weiler, S.; Barbui, C.; Raschi, E.; Gastaldon, C.
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System
2024 Cecco, S.; Puligheddu, S.; Fusaroli, M.; Gerratana, L.; Yan, M.; Zamagni, C.; De Ponti, F.; Raschi, E.
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS
2024 Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E.
Environmental sustainability-an essential component of rational use of medicines
2024 Giunchi, V; Fusaroli, M; Linder, E; Villén, J; Raschi, E; Lunghi, C; Wettermark, B; Poluzzi, E; Nekoro, M
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward
2024 Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F.
Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports A Note of Caution
2024 Fusaroli, M.; Khouri, C.; Poluzzi, E.; De Ponti, F.; Salvo, F.; Raschi, E.
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis
2024 Raschi, E.; Salvo, F.; Bate, A.; De Ponti, F.; Poluzzi, E.; Tuccori, M.; van Puijenbroek, E.; Joshi, N.; Khouri, C.
Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase
2024 Noseda, R.; Bedussi, F.; Giunchi, V.; Fusaroli, M.; Raschi, E.; Ceschi, A.
Symmetrical cutaneous rash in two women.
2024 Orioni G, Velez-Pelaez MC, Starace MVR, Tengattini V, Raschi E, La Placa M.
The evolving role of disproportionality analysis in pharmacovigilance
2024 Fusaroli, M.; Raschi, E.; Poluzzi, E.; Hauben, M.
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement
2024 Fusaroli, M.; Salvo, F.; Begaud, B.; Alshammari, T. M.; Bate, A.; Battini, V.; Brueckner, A.; Candore, G.; Carnovale, C.; Crisafulli, S.; Cutroneo, P. M.; Dolladille, C.; Drici, M. -D.; Faillie, J. -L.; Goldman, A.; Hauben, M.; Herdeiro, M. T.; Mahaux, O.; Manlik, K.; Montastruc, F.; Noguchi, Y.; Noren, G. N.; Noseda, R.; Onakpoya, I. J.; Pariente, A.; Poluzzi, E.; Salem, M.; Sartori, D.; Trinh, N. T. H.; Tuccori, M.; van Hunsel, F.; van Puijenbroek, E.; Raschi, E.; Khouri, C.
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration
2024 Fusaroli, M.; Salvo, F.; Begaud, B.; Alshammari, T. M.; Bate, A.; Battini, V.; Brueckner, A.; Candore, G.; Carnovale, C.; Crisafulli, S.; Cutroneo, P. M.; Dolladille, C.; Drici, M. -D.; Faillie, J. -L.; Goldman, A.; Hauben, M.; Herdeiro, M. T.; Mahaux, O.; Manlik, K.; Montastruc, F.; Noguchi, Y.; Noren, G. N.; Noseda, R.; Onakpoya, I. J.; Pariente, A.; Poluzzi, E.; Salem, M.; Sartori, D.; Trinh, N. T. H.; Tuccori, M.; van Hunsel, F.; van Puijenbroek, E.; Raschi, E.; Khouri, C.
The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline
2024 Fusaroli, M.; Salvo, F.; Khouri, C.; Raschi, E.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study | Donati, M.; Giunchi, V.; Grillini, G.; Domenicali, M.; Lunardelli, M. L.; Pasini, V.; Milandri, S....; Mussoni, M.; Pieraccini, F.; Sangiorgi, E.; Raschi, E.; Colonnello, V.; Lunghi, C.; Poluzzi, E. | 2025-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | Donati etal. EurJCliniPharm 2025.pdf; 228_2025_3852_MOESM1_ESM.docx |
| Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure | Armillotta, Matteo; Angeli, Francesco; Paolisso, Pasquale; Belmonte, Marta; Raschi, Emanuel; Di D...almazi, Guido; Amicone, Sara; Canton, Lisa; Fedele, Damiano; Suma, Nicole; Foà, Alberto; Bergamaschi, Luca; Pizzi, Carmine | 2025-01-01 | PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | armill SGLT2i.pdf |
| Comment on “evaluation of anticancer therapy-related dermatologic adverse events: insight from Food and Drug Administration’s adverse event reporting system dataset”. | Raschi, E; La Placa, M; Starace, M. | 2025-01-01 | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Safety of Hydroxychloroquine: What a Dermatologist Should Know | Rapparini, Luca; Cedirian, Stephano; La Placa, Michelangelo; Piraccini, Bianca Maria; Raschi, Ema...nuel; Starace, Michela | 2025-01-01 | AMERICAN JOURNAL OF CLINICAL DERMATOLOGY | - | 1.01 Articolo in rivista | 40257_2025_Article_919.pdf |
| The interface of depression and diabetes: treatment considerations | Fanelli, G.; Raschi, E.; Hafez, G.; Matura, S.; Schiweck, C.; Poluzzi, E.; Lunghi, C. | 2025-01-01 | TRANSLATIONAL PSYCHIATRY | - | 1.01 Articolo in rivista | Fanelli et al. Translational psychiatry 2025.pdf |
| Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals | Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | Lunghi et al. Drug Safety 2024.pdf; 40264_2024_1453_MOESM1_ESM.pdf |
| Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database | De Filippis, R.; Kane, J. M.; Arzenton, E.; Moretti, U.; Raschi, E.; Trifiro, G.; Barbui, C.; De ...Fazio, P.; Gastaldon, C.; Schoretsanitis, G. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | DRESS Antipsychotics Vigibase DS.pdf; DRESS Antipsychotics Vigibase DS Suppl.pdf |
| Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality | Schoretsanitis, G.; Weiler, S.; Barbui, C.; Raschi, E.; Gastaldon, C. | 2024-01-01 | JAMA NETWORK OPEN | - | 1.01 Articolo in rivista | GLP-1 suicidality JAMA Network Open.pdf; GLP-1 suicidality JAMA Network Open suppl.pdf |
| Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System | Cecco, S.; Puligheddu, S.; Fusaroli, M.; Gerratana, L.; Yan, M.; Zamagni, C.; De Ponti, F.; Rasch...i, E. | 2024-01-01 | TARGETED ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS | Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-023-01391-4.pdf; 40264_2023_1391_MOESM1_ESM.docx |
| Environmental sustainability-an essential component of rational use of medicines | Giunchi, V; Fusaroli, M; Linder, E; Villén, J; Raschi, E; Lunghi, C; Wettermark, B; Poluzzi, E; N...ekoro, M | 2024-01-01 | INTERNATIONAL JOURNAL OF PHARMACY PRACTICE | - | 1.01 Articolo in rivista | - |
| Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward | Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F. | 2024-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports A Note of Caution | Fusaroli, M.; Khouri, C.; Poluzzi, E.; De Ponti, F.; Salvo, F.; Raschi, E. | 2024-01-01 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis | Raschi, E.; Salvo, F.; Bate, A.; De Ponti, F.; Poluzzi, E.; Tuccori, M.; van Puijenbroek, E.; Jos...hi, N.; Khouri, C. | 2024-01-01 | DRUG SAFETY | - | 1.04 Replica / breve intervento (e simili) | - |
| Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase | Noseda, R.; Bedussi, F.; Giunchi, V.; Fusaroli, M.; Raschi, E.; Ceschi, A. | 2024-01-01 | JOURNAL FOR IMMUNOTHERAPY OF CANCER | - | 1.01 Articolo in rivista | e009902.full.pdf |
| Symmetrical cutaneous rash in two women. | Orioni G, Velez-Pelaez MC, Starace MVR, Tengattini V, Raschi E, La Placa M. | 2024-01-01 | CLINICAL CASE REPORTS | - | 1.01 Articolo in rivista | Clinical Case Reports - 2024 - Orioni.pdf |
| The evolving role of disproportionality analysis in pharmacovigilance | Fusaroli, M.; Raschi, E.; Poluzzi, E.; Hauben, M. | 2024-01-01 | EXPERT OPINION ON DRUG SAFETY | - | 1.01 Articolo in rivista | - |
| The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement | Fusaroli, M.; Salvo, F.; Begaud, B.; Alshammari, T. M.; Bate, A.; Battini, V.; Brueckner, A.; Can...dore, G.; Carnovale, C.; Crisafulli, S.; Cutroneo, P. M.; Dolladille, C.; Drici, M. -D.; Faillie, J. -L.; Goldman, A.; Hauben, M.; Herdeiro, M. T.; Mahaux, O.; Manlik, K.; Montastruc, F.; Noguchi, Y.; Noren, G. N.; Noseda, R.; Onakpoya, I. J.; Pariente, A.; Poluzzi, E.; Salem, M.; Sartori, D.; Trinh, N. T. H.; Tuccori, M.; van Hunsel, F.; van Puijenbroek, E.; Raschi, E.; Khouri, C. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-024-01421-9.pdf; 40264_2024_1421_MOESM1_ESM.pdf |
| The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration | Fusaroli, M.; Salvo, F.; Begaud, B.; Alshammari, T. M.; Bate, A.; Battini, V.; Brueckner, A.; Can...dore, G.; Carnovale, C.; Crisafulli, S.; Cutroneo, P. M.; Dolladille, C.; Drici, M. -D.; Faillie, J. -L.; Goldman, A.; Hauben, M.; Herdeiro, M. T.; Mahaux, O.; Manlik, K.; Montastruc, F.; Noguchi, Y.; Noren, G. N.; Noseda, R.; Onakpoya, I. J.; Pariente, A.; Poluzzi, E.; Salem, M.; Sartori, D.; Trinh, N. T. H.; Tuccori, M.; van Hunsel, F.; van Puijenbroek, E.; Raschi, E.; Khouri, C. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-024-01423-7 (1).pdf |
| The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline | Fusaroli, M.; Salvo, F.; Khouri, C.; Raschi, E. | 2024-01-01 | FRONTIERS IN PHARMACOLOGY | - | 1.01 Articolo in rivista | fphar-15-1488725.pdf; Data Sheet 1.PDF |